STOCK TITAN

NexGel, Inc - NXGL STOCK NEWS

Welcome to our dedicated page for NexGel news (Ticker: NXGL), a resource for investors and traders seeking the latest updates and insights on NexGel stock.

NexGel, Inc (symbol: NXGL) specializes in the manufacture of advanced hydrogel solutions. The company's core business revolves around creating unique trans-dermal delivery systems initially developed and FDA-approved for the hospital wound care market. Today, NexGel has expanded its offerings to include consumer over-the-counter (OTC) products, prescription (Rx) applications, medical devices, and cosmetic products.

NexGel Inc is renowned for its high water content, electron beam cross-linked, aqueous polymer hydrogels. These gels are integral to various applications such as wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company's expertise lies in producing custom gels utilizing proprietary manufacturing technologies. The hydrogels and consumer products are created through a combination of proprietary and non-proprietary mixing, coating, and cross-linking technologies.

The company's recent achievements and current projects highlight its ongoing commitment to innovation and excellence in the hydrogel market. NexGel continually explores new partnerships and collaborations to enhance its product offerings and market reach.

For investors and stakeholders, it is important to note the company's strategic communications are managed by KCSA, with Valter Pinto serving as the Managing Director. NexGel’s financial condition and market performance are presented through regular updates, ensuring transparency and keeping investors well-informed.

For the latest developments, financial updates, and detailed information about NexGel, Inc, please refer to the following contact details:
Investor Contact: Valter Pinto, Managing Director, KCSA Strategic Communications
Phone: 212.896.1254
Email: valter@kcsa.com

Rhea-AI Summary
NEXGEL, Inc. will report its financial results for Q3 2023 on November 13, 2023. The company is a leading provider of hydrogel products for healthcare and consumer applications. A conference call will be held at 4:30 P.M. ET on the same day, which can be accessed through the Investor Relations website. The webcast will be archived for approximately 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
conferences earnings
-
Rhea-AI Summary
NEXGEL, Inc. has announced a supply agreement with AbbVie Inc. for the provision of gel pads to be used with AbbVie's Rapid Acoustic Pulse device. The gel pads, based on NEXGEL's hydrogel technology, will be a crucial component of the body contouring device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
NEXGEL CEO to participate in LD Micro Main Event XVI on October 3rd – 5th in Los Angeles.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.91%
Tags
-
Rhea-AI Summary
NEXGEL, Inc. to report Q2 2023 financial results on August 14, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.36%
Tags
conferences earnings
-
Rhea-AI Summary
NEXGEL, Inc. announced a new strategic relationship with Enigma Health for retail distribution and marketing services in North America. Enigma will also provide services for Moiety, Inc. CEO Adam Levy stated that they are expanding their distribution channels and leveraging Enigma Health's expertise to deliver their hydrogel topical patches directly to consumers. The joint venture will be led by Joe Magnacca and George Lamont, who have extensive experience in the retail distribution industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.25%
Tags
partnership
Rhea-AI Summary
NEXGEL CEO, Adam Levy, to participate in a virtual fireside chat at Maxim Group Virtual Healthcare Conference on June 20th - 22nd.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
conferences earnings

FAQ

What is the current stock price of NexGel (NXGL)?

The current stock price of NexGel (NXGL) is $4.73 as of December 20, 2024.

What is the market cap of NexGel (NXGL)?

The market cap of NexGel (NXGL) is approximately 32.5M.

What does NexGel, Inc specialize in?

NexGel, Inc specializes in manufacturing advanced hydrogel solutions used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics.

What are the primary applications of NexGel's products?

NexGel's hydrogels are used for wound care, medical diagnostics, transdermal drug delivery, and in cosmetics.

What is unique about NexGel's manufacturing technology?

NexGel uses proprietary and non-proprietary mixing, coating, and cross-linking technologies to create high water content, electron beam cross-linked polymer hydrogels.

Who handles investor relations for NexGel?

Investor relations for NexGel are managed by Valter Pinto, the Managing Director at KCSA Strategic Communications.

How did NexGel begin its journey in the hydrogel market?

NexGel began by developing FDA-approved trans-dermal delivery systems for the hospital wound care market.

What is the significance of NexGel’s hydrogels in consumer products?

NexGel's hydrogels are significant in consumer products for their applications in over-the-counter medications, prescription drugs, medical devices, and cosmetics.

How can one stay updated with NexGel's latest news and developments?

You can stay updated with NexGel's latest news and developments by contacting Valter Pinto at KCSA Strategic Communications or following company announcements.

What financial information is available for NexGel investors?

NexGel provides regular financial updates and detailed reports through their investor relations managed by KCSA, ensuring transparency for their stakeholders.

Where can I find more detailed information about NexGel, Inc?

For more detailed information about NexGel, Inc, you can reach out to their investor contact, Valter Pinto, at KCSA Strategic Communications.

NexGel, Inc

Nasdaq:NXGL

NXGL Rankings

NXGL Stock Data

32.49M
5.28M
20.09%
2.95%
0.4%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LANGHORNE